SCOPUS 정보 검색 플랫폼

Intensive Care Medicine

Volumn 40, Issue 7, 2014, Pages 1033-1035

Amikacin dosing in the ICU: We now know more, but still not enough...

(2) De Rosa, Francesco G a,b Roberts, Jason A c,d,e

a UNIVERSITY OF TURIN (Italy)

b AMEDEO DI SAVOIA HOSPITAL (Italy)

c UNIVERSITY OF QUEENSLAND (Australia)

d ROYAL BRISBANE AND WOMEN'S HOSPITAL (Australia)

e UNIVERSITY OF LIVERPOOL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT;

CRITICALLY ILL PATIENT; EDITORIAL; HUMAN; INTENSIVE CARE UNIT; LOADING DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; BLOOD; BODY WEIGHT; FEMALE; MALE;

AMIKACIN; ANTI-BACTERIAL AGENTS; BODY WEIGHT; FEMALE; HUMANS; MALE;

EID: 84903301744 PISSN: 03424642 EISSN: 14321238 Source Type: Journal
DOI: 10.1007/s00134-014-3308-6 Document Type: Editorial

Times cited : (3)

References (6)

1
- 84903273854
- Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen
- doi:10.1007/s00134-014-3276-x
- de Montmollin E, Bouadma L, Gault N, Mourvillier B, Mariotte E, Chemam S, Massias L, Papy E, Tubach F, Wolff M, Sonneville R (2014) Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen. Intensive Care Med. doi:10.1007/s00134-014- 3276-x
- (2014) Intensive Care Med
- De Montmollin, E.¹ Bouadma, L.² Gault, N.³ Mourvillier, B.⁴ Mariotte, E.⁵ Chemam, S.⁶ Massias, L.⁷ Papy, E.⁸ Tubach, F.⁹ Wolff, M.¹⁰ Sonneville, R.¹¹

2
- 83155166316
- Using PK/PD to optimize antibiotic dosing for critically ill patients
- Roberts JA (2011) Using PK/PD to optimize antibiotic dosing for critically ill patients. Curr Pharm Biotechnol 12:2070-2079
- (2011) Curr Pharm Biotechnol , vol.12 , pp. 2070-2079
- Roberts, J.A.¹

3
- 25144506949
- Quantification of lean bodyweight
- DOI 10.2165/00003088-200544100-00004
- Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B (2005) Quantification of lean bodyweight. Clin Pharmacokinet 44:1051-1065 (Pubitemid 41356391)
- (2005) Clinical Pharmacokinetics , vol.44 , Issue.10 , pp. 1051-1065
- Janmahasatian, S.¹ Duffull, S.B.² Ash, S.³ Ward, L.C.⁴ Byrne, N.M.⁵ Green, B.⁶

4
- 79951562557
- Antibiotic dosing in the 'at risk' critically ill patient: Linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients
- Roberts JA, Roberts MS, Semark A, Udy AA, Kirkpatrick CM, Paterson DL, Roberts MJ, Kruger P, Lipman J (2011) Antibiotic dosing in the 'at risk' critically ill patient: linking pathophysiology with pharmacokinetics/ pharmacodynamics in sepsis and trauma patients. BMC Anesthesiol 11:3
- (2011) BMC Anesthesiol , vol.11 , pp. 3
- Roberts, J.A.¹ Roberts, M.S.² Semark, A.³ Udy, A.A.⁴ Kirkpatrick, C.M.⁵ Paterson, D.L.⁶ Roberts, M.J.⁷ Kruger, P.⁸ Lipman, J.⁹

5
- 84897414453
- DALI: Defining antibiotic levels in intensive care unit patients: Are current beta-lactam antibiotic doses sufficient for critically ill patients?
- Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J, Study D (2014) DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58:1072-1083
- (2014) Clin Infect Dis , vol.58 , pp. 1072-1083
- Roberts, J.A.¹ Paul, S.K.² Akova, M.³ Bassetti, M.⁴ De Waele, J.J.⁵ Dimopoulos, G.⁶ Kaukonen, K.M.⁷ Koulenti, D.⁸ Martin, C.⁹ Montravers, P.¹⁰ Rello, J.¹¹ Rhodes, A.¹² Starr, T.¹³ Wallis, S.C.¹⁴ Lipman, J.¹⁵ Study, D.¹⁶

6
- 84899530823
- Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study
- on behalf of the DALI Study authors
- Roberts JA, Stove V, De Waele JJ, Sipinkoski B, McWhinney B, Ungerer JP, Akova M, Bassetti M, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J, on behalf of the DALI Study authors (2014) Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI Study. Int J Antimicrob Agents 43(5):423-430
- (2014) Int J Antimicrob Agents , vol.43 , Issue.5 , pp. 423-430
- Roberts, J.A.¹ Stove, V.² De Waele, J.J.³ Sipinkoski, B.⁴ McWhinney, B.⁵ Ungerer, J.P.⁶ Akova, M.⁷ Bassetti, M.⁸ Dimopoulos, G.⁹ Kaukonen, K.M.¹⁰ Koulenti, D.¹¹ Martin, C.¹² Montravers, P.¹³ Rello, J.¹⁴ Rhodes, A.¹⁵ Starr, T.¹⁶ Wallis, S.C.¹⁷ Lipman, J.¹⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.